ISSN 1849-9031 (Online)

ISSN 1849-8922    (Print)

Instructions for authors

EOM will accept the following article types:

Original investigation
This contribution should contain original controlled experimental data of basic and clinical research. The manuscript should be organized in the following sections: Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Figure Legends, Tables, Figures.

These papers represent scholarly literature review of a current topic. The authors are not obligate to contact editors prior to submission. The review process is the same as with original articles. This type of article does not have a strict limit in word and reference number although the editorial recommendation is that the article does not exceed 8000 words and 350 references.

Approach to the patient
These are review papers dealing with the clinical aspects of a disease. The authors should make a clinically oriented review of the field based on a single case presentation.

This contribution should be based on a rigorous methodological/statistical approach described in detail in the methods section applied to a relevant clinical or basic issue. This work could also be submitted to statistical revision.

Interesting and important theoretical papers dealing with cutting edge areas in clinical and basic medicine will be considered in this section. The main goal of this paper is to present a novel idea and to provide a short review of the literature supporting this idea.

Case Reports

Case reports will be considered for publication only if they present a case revealing novel and important insights into a condition’s pathogenesis, presentation, and/or management. The case report provides several important references but does not include a scholarly review of the literature. These manuscripts should be 1200 words or less, with no more than two figures and tables and 10 references.

Position and Consensus Statements related to the endocrine and metabolic health standards and healthcare practices may be submitted by professional societies, task forces, and other consortia. All such submissions will be subjected to peer review, must be modifiable in response to criticisms.

Letter to the Editor
These articles are short commentaries related to specific points of agreement or disagreement with the work that has been published recently in the journal. Short research articles or case reports may be also submitted to this category. Text is limited to 750 words, with no abstract. There may be 1 figure, up to 5 references, and no more than 3 authors.


These are soliced papers only, authored by the members of the editorial board. These papers should have no more than 1500 words and 30 references.

Manuscript preparation

All articles should be written in good English (American or British language is accepted, but not a mixture of these).

All articles should be accompanied by a cover letter, which is submitted apart from the main manuscript. It should include the short description of why the paper should be published.

Manuscripts should be divided into the following sections:
Title page, Abstract, Introduction, Materials and methods, Results, Discussion, References, Figure legends, Tables, Figures. The various sections of your manuscript should be numbered, starting from the introduction.

Title page

Title page should include the following:

  • Full title
  • Corresponding authors and their associated institutions
  • Short title (no longer than 50 characters)
  • Word count
  • Corresponding author with contact details
  • Funding statement: All manuscripts must be provided with a statement regarding financial support and funding
  • Conflict of interest statement: all manuscripts must include a statement concerning potential conflicts of interests
  • Patient consent when applicable
  • Keywords (2 to 6 words)

The abstract should be no longer than 250 words and should be divided into the following sections: purpose, methods, results, and conclusions. Case reports and review papers should have unstructured abstract.

The introduction should provide background information on the topic and review of relevant literature. It should describe the focus and purpose of the paper, and provide an overview of the paper’s content.

Materials and Methods
This section should be described in sufficient detail for other investigators to repeat the work

Research findings and statistical analyses are presented in this section. The results should be displayed using Tables, Charts, or Figures along with a written explanation

Interpretations of results and review of relevant literature.

Author contributions

Authors contributions should be added before the references as a separate section. Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure. All authors must fulfill the authorship criteria as defined by ICMJE ( All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Reference citations should be identified by numbers in square brackets followed by a period [1]. The entries in the list should be numbered consecutively
• References in the reference list must be double-spaced and numbered consecutively as they are cited. The surnames of all authors should be provided with name or second name as initials
• If the citation has more than six authors, only first six should be written and the rest replaced with “et al.”
• Use the standard abbreviation of a journal’s name (ISSN List of Title Word Abbreviations)
• Do not use references to personal communications, unpublished data, or manuscripts either “in preparation” or “submitted for publication”
• Examples of references:

  1. Journal article: Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ, et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J Bone Miner Res 2010;25:866-72.
  2. Ahead of print article: Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002;100:Epub 2002 Jul 5.
  3. Book: Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff’s headache and other head pain. 7th ed. Oxford, England: Oxford University Press, 2001:57-72.
  4. Other literature and online material: Kuczmarski RJ, Ogden CL, Grammer-Strawn LM, et al. CDC growth charts: United States. Advance data from vital and health statistics. No. 314. Hyattsville, Md.: National Center for Health Statistics, 2000. (DHHS publication no. (PHS) 2000-1250 0-0431.)
    U.S. positions on selected issues at the third negotiating session of the Framework Convention on Tobacco Control. Washington, D.C.: Committee on Government Reform, 2002. (Accessed March 4, 2002, at


  • Figures should be mentioned throughout the text where appropriate
  • Label figures using Figure 1, Figure 2 etc. followed by an informative figure caption
  • Figure captions should be provided after the references section
  • Figures are submitted separately from manuscript
  • Indicate what graphics program was used to create the artwork.

• Number all tables using Arabic numerals
• Each table should be provided with an informative table caption
• Tables should be placed after the figure captions

Text Formatting
• Manuscripts should be submitted in Word
• Use a 12-point Times Roman font for text
• Double space your manuscript
• Use italics for emphasis
• Use the automatic page numbering function to number the pages
• Do not use field functions
• Use tab stops for indents
• Use the table function to make tables
• Use the equation editor or MathType for equations
• Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Scientific style
• Use internationally accepted signs and symbols for units (SI units)

Manuscript Submission

All manuscripts must be submitted via online submission system ( Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Conflict of Interest

A Conflict of Interest disclosure statement is REQUIRED to be included within the manuscript text, and should be located in the title page. Authors must declare the potential conflict of interest, or no conflict of interest. If no conflict exists, authors should state: The authors declare that they have no conflict of interest.
Potential conflicts of interest do not imply impropriety but could either directly or indirectly, purposely or inadvertently affect the conduct, outcome, or reporting of any scholarly activity. Potential conflicts of interest exist when an author is related to a for-profit company or institution in any of the following ways:
• Employment
• Consultancies in the last 3 years (please list)
• Honoraria in the last 3 years (please list)
• Stock ownership/ options other than mutual funds (current; please list)
• Expert testimony in the last 3 years (please list)
• Grants received in the last 3 years (please list)
• Grants pending (please list)
• Patents received
• Patents pending
• Royalties (describe)
• Other relationships (please specify)

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts.
Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

Reporting clinical trials

Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram can be found on

Registration of clinical trials

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors (ICMJE, recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.

Informed consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.